National Institute on Drug Abuse
Most people who follow a program maintain more than ten percent of their weight post-therapy
Pharmaceutical companies and non-profit organizations offer these programs, as do certain government agencies and other third parties
How D2Type is aligned At D2Type, our app helps users work toward normal glycemic index through sustainable, daily behaviors, not crash diets, but by personalizing: Glucose-aware routines & meal timing Activity & recovery to boost insulin sensitivity Sleep & stress patterns that influence glycemia (While body weight can change, our north star is metabolic health and remission signals.) This study strengthens our conviction: precision lifestyle + glycemic targets is a pragmatic, scalable path to prevention
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS Albiglutide (Tanzeum, once weekly), dulaglutide (Trulicity, once weekly), exenatide (Byetta, twice daily